News from the healthcare data industry
SAN FRANCISCO, Feb. 14, 2022 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board. The new board members will help...
Radicle Science launches several blinded placebo-controlled clinical trials on rare cannabinoids with 10,000 participants in the first half of 2022 on the heels of completing 25 large-scale CBD studies in...
February 07, 2022 09:24 AM Eastern Standard Time PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc. and CVS Health (NYSE: CVS) today announced a collaboration to expand clinical trial access and engagement for patients at select...
Karen Ooms, Executive Vice President and Head of Statistics, Quanticate 02.04.22Today more and more pharmaceutical companies are turning to real-world evidence (RWE) to understand the real-life effectiveness of their drug...
UBC enters into partnership with Seqster for a best-in-class patient engagement platform to provide real-time, real-world connectivity Feb 03, 2022, 07:00 ET SAN DIEGO and BLUE BELL, Pa., Feb. 3, 2022 /PRNewswire/ — UBC, a...
by Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI 01/24/2022 Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the...
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these...
Real-world evidence-based software product empowers life sciences companies to improve the recruitment of diverse and underrepresented patient populations January 26, 2022 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health,...
January 24, 2022 04:00 PM Eastern Standard Time SYDNEY–(BUSINESS WIRE)–Global healthcare data technology company, Prospection, and leading Asia-Pacific biotech specialist CRO, Novotech Health Holdings, announce a strategic partnership to combine the power...
Tempus, a leader in artificial intelligence and precision medicine, today announced the commencement of an open label phase II study, in collaboration with GlaxoSmithKline (GSK) to evaluate the efficacy and...